Affymax, Inc. (NASDAQOTH:AFFY)
CAPS Rating:
The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.
The Company is a biopharmaceutical company developing novel peptide-based drug candidates to improve the treatment of serious and often life-threatening conditions.
Recs
I have a theory that the polysorbate 20 found in Omontys is what's triggering the anaphylaxis symptoms. If so it's a simple matter of switching the ingredient out to keep it viable
http://www.ncbi.nlm.nih.gov/pubmed/16400901
Bought IRL at $2.36